Demographic Health

Listen to article(2 minutes)It’s a nervous parent’s dream: finding out your children’s risk of a driving accident before they get behind the wheel of a car.Many of us might think we can predict what kind of drivers our kids will be, but it’s impossible to know whether teens will brake too hard or steer straight when they finally are able to drive. Insurance companies have apps to track teen driving, but that information only comes after they’re on the road.Copyright ©2024Dow Jones & Company, Inc. All Rights Reserved.…

While the virus often leads to mild, coldlike symptoms, it is the leading cause of hospitalization of infants in the U.S. While the virus often leads to mild, coldlike symptoms, it is the leading cause of hospitalization of infants in the U.S. FOLLOW US ON GOOGLE NEWS Read original article here Denial of responsibility! Techno Blender is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all…

The Food and Drug Administration approved the first over-the-counter birth-control pill, significantly expanding access to contraception among women across the U.S.   The Food and Drug Administration approved the first over-the-counter birth-control pill, significantly expanding access to contraception among women across the U.S.   FOLLOW US ON GOOGLE NEWS Read original article here Denial of responsibility! Techno Blender is an automatic aggregator of the all world’s media. In each content, the hyperlink to…

HealthHealth providers struggle to hire nurses from abroad as staffing problems worsen HealthHealth providers struggle to hire nurses from abroad as staffing problems worsen FOLLOW US ON GOOGLE NEWS Read original article here Denial of responsibility! Techno Blender is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not…

For women weighing their contraception options, there are several things to consider. For women weighing their contraception options, there are several things to consider. FOLLOW US ON GOOGLE NEWS Read original article here Denial of responsibility! Techno Blender is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not…

GSK said Wednesday that its Arexvy respiratory syncytial virus vaccine for older adults has been approved by the U.S. Food and Drug Administration for the prevention of lower respiratory tract disease. The pharmaceutical company said the approval—based on positive Phase 3 trial data that showed exceptional efficacy in older adults—is the first for individuals age 60 years or older. GSK said Wednesday that its Arexvy respiratory syncytial virus vaccine for older adults has been…

Doctors take action as early and aggressively as possible in treating severe cases. Doctors take action as early and aggressively as possible in treating severe cases. FOLLOW US ON GOOGLE NEWS Read original article here Denial of responsibility! Techno Blender is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want…

A drug used to extend the lives of people with advanced prostate cancer is in short supply and will be for months, leaving some patients with no treatment option as the manufacturer works to ramp up production.  The Food and Drug Administration said last week the availability of Pluvicto is limited as manufacturer Novartis AG struggles to meet demand. The drugmaker said the shortage stems from manufacturing and delivery issues.  Novartis said it is prioritizing the supply for patients who…

An experimental drug from Eli Lilly LLY 0.61% & Co. failed to prevent memory loss in a study of healthy older people with a high risk of developing clinical Alzheimer’s disease in one of the first studies aimed at stopping symptoms before they start.  The drug was no better than a placebo over about 4½ years of treatment at slowing patients’ decline in areas including memory and the ability to plan and complete tasks, Lilly said…

Federal regulators approved a drug to treat a debilitating disease using data collected about patients over decades, creating an opening for researchers of other rare conditions who often struggle to prove their treatments work.The Food and Drug Administration on Tuesday approved Reata Pharmaceuticals Inc.’s drug Skyclarys, or omaveloxolone, for treating the neurological disorder Friedreich’s ataxia in adults and adolescents age 16 and older.…